Some of these genes (HMGA2, MMP13, BIRC7, and PLA2G2D) have been reported to be overexpressed in various cancers, including lung adenocarcinoma, and are associated with tumor progression and metastasis [51-54], supporting their potential as biomarkers for PD-1 immunotherapy. This evidence concerns the gene MMP13 and lung adenocarcinoma.